Apogee Therapeutics
Apogee Therapeutics Inc is a clinical-stage biotechnology company headquartered in Waltham, Massachusetts. The company focuses on discovering and developing novel antibody therapeutics for immunological and inflammatory disorders. Its pipeline targets conditions such as atopic dermatitis, asthma, chronic obstructive pulmonary disease, and related inflammatory diseases. Revenue is primarily derived from future commercial product distribution, research collaborations, and licensing agreements. The company targets patients and healthcare providers specializing in dermatology, immunology, and respiratory medicine. Apogee Therapeutics Inc is publicly traded on the Nasdaq Global Market.
2 of the funds FundTelligence covers report a position in Apogee Therapeutics.
- Legal name
- Apogee Therapeutics Inc
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 2
Funds holding Apogee Therapeutics
- Schroder ISF Healthcare Innovation — Schroders · 0.65 % (full portfolio disclosed, June 2026)
- JPM US Small Cap Growth Fund — JPM · 0.07 % (full portfolio disclosed, June 2026)